Borosilicate Glass Tube USP Type I Market Size, Share | 2030
Borosilicate Glass Tube USP Type I Market Size, Share | 2030
Segments - LAMEA Borosilicate Glass Tube USP Type I Market by Packaging (Parenteral Products and Non-Parenteral Products), By Type (Ampoules, Vials, Syringes, and Others), By End-users (Chemical Companies, Pharma Companies, Laboratories, and Others), and Region (Latin America and Middle East & Africa) - Latin America and Middle East & Africa Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
Upcoming
| Report ID :MC-2623
| 4.4 Rating
| 76 Reviews
| 173 Pages
| Format :
Report Description
Market Outlook:
The LAMEA borosilicate glass tube USP Type I market was valued at USD 1,035.4 Mn in 2020 and is projected to reach USD 2,698.4 Mn by 2028, expanding at a CAGR of 12.9% during the forecast period. Borosilicate Glass Tube USP Type I is widely used in pharmaceutical industries. The type I borosilicate glass tube is largely used for packaging those products which are alkaline in nature or will become alkaline over a certain period of time.
Market Dynamics
The global need for borosilicate glass tubes is growing in line with the rapid development of industry, particularly in the laboratory apparatus sectors. Borosilicate glass has long been used in science labs and industrial settings, as well as for kitchenware and high-end wine glasses, because of its longevity and resilience to chemical changes. It is frequently more expensive than soda-lime glass due to its excellent quality. Though borosilicate glass is resistant to thermal shock than tempered glass, it can still break with sufficiently high-temperature fluctuations (more on this below). It is also more likely to break if dropped than tempered glass.
The pharmaceutical industries increasing demand for sterile medical packaging products would propel the market forward over the forecast period. During the year 2020, the pharmaceutical sector saw unprecedented demand, with significant resources required to make a COVID-19 vaccine as rapidly as possible. The major players are also focusing on the providing of borosilicate glass tubing to the vaccine vials.
Type I borosilicate glass is utilized for parenteral primary packaging all over the globe. It is a material with high amounts of boron oxide (around 10%), which is linked to high hydrolytic resistance and a low coefficient of thermal expansion. The continually expanding pharmaceutical industry around the globe is propelling the LAMEA Borosilicate Glass Tube USP Type I Market growth. The usage of glass for pharmaceutical packaging products has increased as a result of stricter restrictions aimed at improving the quality and integrity of domestically manufactured medications.
Globally the pharmaceutical industry is growing which helps in boosting the growth of the market during the forecast period. Due to the stringent laws the integrity and quality of domestically manufactured drugs is enhancing owing to which the use of type I borosilicate glass for pharmaceutical packaging products is increasing. Furthermore, in pharmaceutical industries the demand for sterile medical packaging products is also increasing which is driving the market during the forecast period.
Over the forecast period, the trend toward plastic usage in developed and developing countries would hamper the growth of the Borosilicate Glass Market. When compared to Borosilicate Glass, plastic apparatus is less expensive. The expansion of the Borosilicate glass market will be hampered by the rising demand for convenient and appealing products as a result of increased urbanization and industrialization, which is driving the plastic industry. The factor that is restraining the growth is the high demand for plastic as compare to glass tubes in developing countries due to industrialization.
Segmental Outlook
By Packaging
Based on packaging, the LAMEA borosilicate glass tube USP Type I market is segmented into parenteral products and non-parenteral products. The parenteral products segment is anticipated to expand at a significant CAGR during the forecast period. Type I borosilicate glass containers are widely used for packaging parenteral drugs.
By Type
Based on type, the LAMEA borosilicate glass tube USP Type I market is segmented into ampoules, vials, syringes, and others. The syringes segment is expected to hold a considerable market share during the forecast period. Type I borosilicate glass provides protection from thermal shock, which is expected to drive the market during the forecast period.
By End-user
Based on end-users, the LAMEA borosilicate glass tube USP Type I market is segmented into chemical companies, pharma companies, laboratories, and others. High heat resistance of type I borosilicate glass used in laboratories is driving the market during the forecast period.
Region Wise Outlook
Based on region, the LAMEA borosilicate glass tube USP Type I market is segmented into Latin America and Middle East & Africa. Increasing demand for type I borosilicate glass, owing to its growing usage for packaging pharmaceutical drugs, is expected to drive the market during the forecast period.
Key Benefits for Industry Participants & Stakeholders
- In-Depth Analysis of the LAMEA borosilicate glass tube USP Type I Market.
- Historical, Current and Projected Market Size in Terms of Value.
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on From LAMEA borosilicate glass tube USP Type I Market Performance
Segments
By Packaging
- Parenteral Products
- Non-Parenteral Products
By Type
- Ampoules
- Vials
- Syringes
- Others
By End-user
- Chemical Companies
- Pharma Companies
- Laboratories
- Others
By Region
- Latin America
- Middle East & Africa
Key Market Players Profiled in the Report
- VWR International, LLC
- Gerresheimer AG
- Corning Incorporated
- SCHOTT AG
- Kavalierglass, a.s.
- DWK Life Sciences
- Cole-Parmer Instrument Company, LLC
- DE DIETRICH PROCESS SYSTEMS
- PGP Glass Pvt. Ltd.
Competitive Landscape
- Key players in the LAMEA Borosilicate Glass Tube USP Type I Market are VWR International, LLC., Gerresheimer AG, Corning Incorporated, SCHOTT AG, Kavalierglass, a.s., DWK Life Sciences, Cole-Parmer Instrument Company, LLC., DE DIETRICH PROCESS SYSTEMS, and PGP Glass Pvt. Ltd.
- The players are adopting key strategies such as product development, geographical expansion, mergers and acquisition, and many other strategies to cater the increasing demand for LAMEA borosilicate glass tube USP Type I. For instance, on June 2021, DE DIETRICH PROCESS SYSTEMS announced a new facility in Wuxi, Jiangsu, China in June 2021. The company is concentrating on expanding its geographic footprint to stay competitive. This new plant increased the production of glass-lined replacement components, allowing the company to serve customers in China and abroad with De Dietrich quality items that exceed all international standards.
Video Summary for Borosilicate Glass Tube USP Type I Market
Frequently Asked Questions
Additional company profiles can be provided on request.
Yes, the report covers various borosilicate glass tube USP Type I market by end-users into chemical companies, pharma companies, laboratories, and others.
According to this Growth Market Reports, the market from LAMEA borosilicate glass tube USP Type I market is likely to register a CAGR of 12.9% during period 2021-2028, with an anticipated valuation of USD 2,698.4 million by the end of the 2028.
In addition to market size (in USD Million) and Company Market Share (in % for base year 2020), other data such as USP (Pharmacopoeial Type 1 Glass Standards) – Overview, Type of Glass Containers Overview - Detailed Outlook on Type 1 Glass (Borosilicate / Neutral), Application of Borosilicate Glass in Pharmaceutical Packaging Detailed Outlook, Impact of Key Regulations, The EP (and the USP) classifies 3 Types of Hydrolytic Resistance – Overview, Glass Containers for Pharmaceutical Use and Production Overview, Macro-economic factors, and COVID-19 Impact on the LAMEA borosilicate glass tube USP Type I market is available in final report.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
The pharmaceutical industries increasing demand for sterile medical packaging products would propel the market forward over the forecast period.
The global need for borosilicate glass tubes is growing in line with the rapid development of industry, particularly in the laboratory apparatus sectors. Borosilicate glass has long been used in science labs and industrial settings, as well as for kitchenware and high-end wine glasses, because of its longevity and resilience to chemical changes.
The market is expected to witness increase in terms of demand during 2019-2020 owing to the positive impact of COVID-19 pandemic on the LAMEA borosilicate glass tube USP Type I market.
The base year considered for the LAMEA borosilicate glass tube USP Type I market report is 2020. The complete analysis period is 2018 to 2028, wherein, 2018 & 2019 are the historic years, and the forecast is provided from 2021 to 2028.
Major Manufactures include VWR International, LLC., Gerresheimer AG, Corning Incorporated, SCHOTT AG, Kavalierglass, a.s., DWK Life Sciences, Cole-Parmer Instrument Company, LLC., DE DIETRICH PROCESS SYSTEMS, and PGP Glass Pvt. Ltd.
Table Of Content
Chapter 1 Executive SummaryChapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Borosilicate Glass Tube USP Type I Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Borosilicate Glass Tube USP Type I Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Borosilicate Glass Tube USP Type I Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Borosilicate Glass Tube USP Type I Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 LAMEA Borosilicate Glass Tube USP Type I Market Size & Forecast, 2018-2028
4.5.1 Borosilicate Glass Tube USP Type I Market Size and Y-o-Y Growth
4.5.2 Borosilicate Glass Tubxe USP Type I Market Absolute $ Opportunity
4.6 USP (Pharmacopoeial Type 1 Glass Standards) - Overview
4.7 Type of Glass Containers Overview - Detailed Outlook on Type 1 Glass (Borosilicate / Neutral)
4.8 Application of Borosilicate Glass in Pharmaceutical Packaging Detailed Outlook
4.9 Impact of Key Regulations
4.10 The EP (and the USP) classifies 3 Types of Hydrolytic Resistance - Overview
4.11 Glass Containers for Pharmaceutical Use and Production Overview
Chapter 5 LAMEA Borosilicate Glass Tube USP Type I Market Analysis and Forecast By Packaging
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Packaging
5.1.2 Basis Point Share (BPS) Analysis By Packaging
5.1.3 Absolute $ Opportunity Assessment By Packaging
5.2 Borosilicate Glass Tube USP Type I Market Size Forecast By Packaging
5.2.1 Parenteral Products
5.2.2 Non-Parenteral Products
5.3 Market Attractiveness Analysis By Packaging
Chapter 6 LAMEA Borosilicate Glass Tube USP Type I Market Analysis and Forecast By Type
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Type
6.1.2 Basis Point Share (BPS) Analysis By Type
6.1.3 Absolute $ Opportunity Assessment By Type
6.2 Borosilicate Glass Tube USP Type I Market Size Forecast By Type
6.2.1 Ampoules
6.2.2 Vials
6.2.3 Syringes
6.2.4 Others
6.3 Market Attractiveness Analysis By Type
Chapter 7 LAMEA Borosilicate Glass Tube USP Type I Market Analysis and Forecast By End-user
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By End-user
7.1.2 Basis Point Share (BPS) Analysis By End-user
7.1.3 Absolute $ Opportunity Assessment By End-user
7.2 Borosilicate Glass Tube USP Type I Market Size Forecast By End-user
7.2.1 Chemical Companies
7.2.2 Pharma Companies
7.2.3 Laboratories
7.2.4 Others
7.3 Market Attractiveness Analysis By End-user
Chapter 8 LAMEA Borosilicate Glass Tube USP Type I Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Borosilicate Glass Tube USP Type I Market Size Forecast by Region
8.2.1 Latin America
8.2.2 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 Latin America Borosilicate Glass Tube USP Type I Analysis and Forecast
10.1 Introduction
10.2 Latin America Borosilicate Glass Tube USP Type I Market Size Forecast by Country
10.2.1 Brazil
10.2.2 Mexico
10.2.3 Rest of Latin America (LATAM)
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Latin America Borosilicate Glass Tube USP Type I Market Size Forecast By Packaging
10.6.1 Parenteral Products
10.6.2 Non-Parenteral Products
10.7 Basis Point Share (BPS) Analysis By Packaging
10.8 Absolute $ Opportunity Assessment By Packaging
10.9 Market Attractiveness Analysis By Packaging
10.10 Latin America Borosilicate Glass Tube USP Type I Market Size Forecast By Type
10.10.1 Ampoules
10.10.2 Vials
10.10.3 Syringes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis By Type
10.12 Absolute $ Opportunity Assessment By Type
10.13 Market Attractiveness Analysis By Type
10.14 Latin America Borosilicate Glass Tube USP Type I Market Size Forecast By End-user
10.14.1 Chemical Companies
10.14.2 Pharma Companies
10.14.3 Laboratories
10.14.4 Others
10.15 Basis Point Share (BPS) Analysis By End-user
10.16 Absolute $ Opportunity Assessment By End-user
10.17 Market Attractiveness Analysis By End-user
Chapter 11 Middle East & Africa (MEA) Borosilicate Glass Tube USP Type I Analysis and Forecast
11.1 Introduction
11.2 Middle East & Africa (MEA) Borosilicate Glass Tube USP Type I Market Size Forecast by Country
11.2.1 Saudi Arabia
11.2.2 South Africa
11.2.3 Botswana
11.2.4 Namibia
11.2.5 UAE
11.2.6 Egypt
11.2.7 Algeria
11.2.8 Rest of Middle East & Africa (MEA)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Middle East & Africa (MEA) Borosilicate Glass Tube USP Type I Market Size Forecast By Packaging
11.6.1 Parenteral Products
11.6.2 Non-Parenteral Products
11.7 Basis Point Share (BPS) Analysis By Packaging
11.8 Absolute $ Opportunity Assessment By Packaging
11.9 Market Attractiveness Analysis By Packaging
11.10 Middle East & Africa (MEA) Borosilicate Glass Tube USP Type I Market Size Forecast By Type
11.10.1 Ampoules
11.10.2 Vials
11.10.3 Syringes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis By Type
11.12 Absolute $ Opportunity Assessment By Type
11.13 Market Attractiveness Analysis By Type
11.14 Middle East & Africa (MEA) Borosilicate Glass Tube USP Type I Market Size Forecast By End-user
11.14.1 Chemical Companies
11.14.2 Pharma Companies
11.14.3 Laboratories
11.14.4 Others
11.15 Basis Point Share (BPS) Analysis By End-user
11.16 Absolute $ Opportunity Assessment By End-user
11.17 Market Attractiveness Analysis By End-user
Chapter 12 Competition Landscape
12.1 Borosilicate Glass Tube USP Type I Market: Competitive Dashboard
12.2 LAMEA Borosilicate Glass Tube USP Type I Market: Market Share Analysis, 2020
12.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
12.3.1 DE DIETRICH PROCESS SYSTEMS
12.3.2 Kavalierglass, a.s.
12.3.3 Corning Incorporated
12.3.4 VWR International, LLC
12.3.5 Gerresheimer AG
12.3.6 SCHOTT AG
12.3.7 DWK Life Sciences
12.3.8 Cole-Parmer Instrument Company, LLC
12.3.9 PGP Glass Pvt. Ltd.
Methodology
Related Reports
Some other reports from this category!
Our Clients
